Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial

NCT01224210 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT01224210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Lead sponsor
Tufts Medical Center
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
March 31, 2020
Enrollment
30 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

portopulmonary hypertension